Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1296-1297
Published online before print April 17, 2008, doi: 10.1161/ATVBAHA.108.165803
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/7/1296    most recent
ATVBAHA.108.165803v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sehayek, E.
Right arrow Articles by Hazen, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sehayek, E.
Right arrow Articles by Hazen, S. L.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28:1296.)
© 2008 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Cholesterol Absorption From the Intestine Is a Major Determinant of Reverse Cholesterol Transport From Peripheral Tissue Macrophages

Ephraim Sehayek; Stanley L. Hazen

From the Departments of Cell Biology and Cardiovascular Medicine, Cleveland Clinic, Ohio.

Correspondence to Ephraim Sehayek, MD, 9500 Euclid Ave, NE-10 Cleveland, OH 44195. E-mail sehayee{at}ccf.org

Objective— We examined the effect of ezetimibe, a cholesterol absorption (CA) inhibitor, and genetic determinants of CA on reverse cholesterol transport (RCT) from subcutaneously injected macrophages using a new dual isotope label technique.

Methods and Results— Treatment of C57BL/6J mice with ezetimibe decreased dietary CA by 86% and increased RCT from peripheral tissue macrophages (PTM) by 6-fold (P<0.0001). Moreover, congenic 14DKK mice with a modest 41% decrease in dietary CA displayed a 67% increase in RCT from PTM (P<0.007).

Conclusions— These findings indicate that pharmacological and genetic modifiers of cholesterol absorption are major determinants of reverse cholesterol transport from peripheral tissue macrophages.


Key Words: atherosclerosis • cholesterol absorption • cholesterol efflux • ezetimibe • macrophage • reverse cholesterol transport




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. E. Greenberg, J. D. Smith, and E. Sehayek
Moderately Decreased Cholesterol Absorption Rates Are Associated With a Large Atheroprotective Effect
Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1745 - 1750.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. J. Rader, E. T. Alexander, G. L. Weibel, J. Billheimer, and G. H. Rothblat
The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis
J. Lipid Res., April 1, 2009; 50(Supplement): S189 - S194.
[Abstract] [Full Text] [PDF]